Nucleic Acids Encoding Desaturases and Modified Plant Oil
First Claim
Patent Images
1. A polynucleotide comprising a nucleic acid selected from the group consisting of:
- a) a nucleic acid having a nucleic acid sequence as shown in any one of SEQ ID NO;
1, 3, 5, 7, 31, 33, 35 or 37;
b) a nucleic acid encoding a polypeptide having an amino acid sequence as shown in any one of SEQ ID NO;
2, 4, 6, 8, 32, 34, 36, or 38;
c) a nucleic acid which has a nucleic acid sequence being at least 60% identical to the nucleic acid sequence as shown in any one of SEQ ID NO;
1, 3, 5, 7, 31, 33, 35 or 37, wherein said nucleic acid encodes a polypeptide having desaturase activity;
d) a nucleic acid encoding a polypeptide having an amino acid sequence being at least 74.1% identical to the amino acid sequence shown in any one of SEQ ID NO;
2, 4, 6, 8, 32, 34, 36, or 38, wherein said nucleic acid encodes a polypeptide having desaturase activity;
e) a nucleic acid which hybridizes under stringent hybridization conditions to the nucleic acid of any one of a) to d), wherein said nucleic acid encodes a polypeptide having desaturase activity;
f) a nucleic acid encoding a fragment of a polypeptide encoded by the nucleic acid sequence of any one of a) to e) having desaturase activity; and
g) a nucleic acid comprising at least 15 contiguous nucleotides of the nucleic acid of any one of a) to f).
5 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to nucleic acids derived from Drechslera tritici-repentis, Cylindorcarpon herteronema, Diploida natalensis, Stagonospora nodorum, Microdochium nivalae and Periplaneta americana. The invention also relates to the individual coding sequences and to proteins encoded by these sequences in combination with other sequences as well as to a process for converting oleic acid to linoleic acid to Iinoleic acid and the production of arachidonic acid, eicosapentaenoic acid and/or docosahexaenoic acid in a plant.
14 Citations
30 Claims
-
1. A polynucleotide comprising a nucleic acid selected from the group consisting of:
-
a) a nucleic acid having a nucleic acid sequence as shown in any one of SEQ ID NO;
1, 3, 5, 7, 31, 33, 35 or 37;b) a nucleic acid encoding a polypeptide having an amino acid sequence as shown in any one of SEQ ID NO;
2, 4, 6, 8, 32, 34, 36, or 38;c) a nucleic acid which has a nucleic acid sequence being at least 60% identical to the nucleic acid sequence as shown in any one of SEQ ID NO;
1, 3, 5, 7, 31, 33, 35 or 37, wherein said nucleic acid encodes a polypeptide having desaturase activity;d) a nucleic acid encoding a polypeptide having an amino acid sequence being at least 74.1% identical to the amino acid sequence shown in any one of SEQ ID NO;
2, 4, 6, 8, 32, 34, 36, or 38, wherein said nucleic acid encodes a polypeptide having desaturase activity;e) a nucleic acid which hybridizes under stringent hybridization conditions to the nucleic acid of any one of a) to d), wherein said nucleic acid encodes a polypeptide having desaturase activity; f) a nucleic acid encoding a fragment of a polypeptide encoded by the nucleic acid sequence of any one of a) to e) having desaturase activity; and g) a nucleic acid comprising at least 15 contiguous nucleotides of the nucleic acid of any one of a) to f). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 17, 18, 19, 20, 21, 22, 23, 26, 27, 28, 29, 30)
-
-
16. (canceled)
-
24. (canceled)
-
25. A cell comprising a nucleic acid molecule selected from the group consisting of:
-
a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO;
1, 3, 5, 7, 31, 33, 35 or 37, wherein the nucleic acid molecule is disrupted by at least one technique selected from the group consisting of a point mutation, a truncation, an inversion, a deletion, an addition, a substitution and homologous recombination;b) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO;
1, 3, 5, 7, 31, 33, 35 or 37, wherein the nucleic acid molecule comprises one or more nucleic acid modifications as compared to the sequence set forth in SEQ ID NO;
1, 3, 5, 7 or 9, wherein the modification is selected from the group consisting of a point mutation, a truncation, an inversion, a deletion, an addition and a substitution; andc) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO;
1, 3, 5, 7, 31, 33, 35 or 37, wherein the regulatory region of the nucleic acid molecule is modified relative to the wild-type regulatory region of the molecule by at least one technique selected from the group consisting of a point mutation, a truncation, an inversion, a deletion, an addition, a substitution and homologous recombination.
-
Specification